KIMS Hospitals shares delivered 200% Return Since Listing; Will Rising Debt Derail Growth?

Synopsis: KIMS Hospitals’ growth plans are driving higher leverage, with debt at Rs 2,800 crore and further capex lined up. However, planned fundraising, controlled leverage targets, and improving operational performance support sustainability. While risks from rising debt remain, strong execution and cash flows are key to maintaining growth momentum.

KIMS Hospitals is an issuer that is receiving significant investor interest as the company is trying to balance its growth with debt levels. The company has been maintaining good revenue growth, but the rise in debt levels due to ongoing capex plans has been a cause of concern. The company’s focus on maintaining leverage, improving operating efficiency, and planned fundraising activities suggests that the company has a structured approach towards maintaining growth even in the short term despite balance sheet concerns.

With a market cap of Rs 26,400 crore, the shares of Krishna Institute of Medical Sciences Ltd are trading at Rs 660 and are trading at a PE of 90 compared to their industry PE of 43.5. The stock has given a return of more than 200% since its listing in July 2021.

Expansion push fuels leverage

KIMS Hospitals is in a phase of expansion, with a debt level of Rs 2,800 crore and another Rs 700 crore of capex planned for the company in the near future. This suggests that the company has a clear strategy for growth, which is focused on capacity addition and scaling up operations. However, it also indicates that the company is in a phase of increased leverage, which has caused concern for investors in the past as well.

In order to support the growth, the company has also planned to put in Rs 1,500 crore for operations and debt repayment, which suggests that the company has adopted a measured approach towards managing its debt obligations. Additionally, the proposed QIP issue in the near future is expected to strengthen the balance sheet and support the capital expenditure without putting pressure on debt levels.

However, it is noteworthy that the management has guided on maintaining a net debt/EBITDA of 2x, which suggests that the company is focused on maintaining leverage at sustainable levels. This indicates that the company, despite being in a phase of increased leverage, is focused on maintaining discipline in managing debt levels.

Operational strength and execution key to sustainability

On the operational front, the management at KIMS Hospitals is still positive, as they expect Q4 performance to be stronger than Q3 with an uptick in ARPOBs (Average Revenue Per Occupied Bed). This could result in stronger cash flows, which are essential to support the increased debt.

Furthermore, the management at KIMS Hospitals has highlighted that there are no immediate supply-side risks, as they maintain 2 to 3 weeks of inventory of drugs with visibility of 3 to 4 months and also have adequate LPG availability.

Overall, though the debt levels are rising and could be a threat to the company in the future, the operational performance is still robust with fundraising plans in place, debt levels under control, and supply-side risks at bay, which suggests that the company can sustain its operational performance in the future.

Overall, the sharp surge in Trident’s share price appears to be a mix of a strong volume-led breakout, a supportive broader market rally, a rebound after a steep correction, and improving sector sentiment, which together have fuelled today’s double-digit gain.

Financials and more 

The revenue from operations for the company stood at Rs 998 crore in Q3 FY26 compared to the Q3 FY25 revenue of Rs 772 crore, up by about 29 per cent YoY. However, the net profit stood at Rs 52 crore in Q3 FY26, down compared to the Rs 92 crore profit in Q3 FY25.

KIMS Hospitals is one of the largest corporate healthcare groups in India, with hospitals in Telangana, Andhra Pradesh, Maharashtra, Karnataka, and Kerala, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at an affordable cost.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post KIMS Hospitals shares delivered 200% Return Since Listing; Will Rising Debt Derail Growth? appeared first on Trade Brains.